ReviewAmerican journal of cancer research2020
The trastuzumab era: current and upcoming targeted HER2+ breast cancer therapies.
Jordyn Kreutzfeldt et al.PubMed ↗Full text ↗
No numbers read from the abstract.
123 papers cite itlatest 60 shown
this paperpooled ittrialcites it